Informe completo: Prevention of Tuberculosis Reactivation

Objetivo:  Questions: - What is the clinical utility of screening for latent tuberculosis infection in people at risk of tuberculosis reactivation? - What is the clinical effectiveness of treating latent tuberculosis infection to prevent tuberculosis reactivation? - What are the evidence-based guidelines for the prevention of tuberculosis reactivation?

Autoría: Canadian Agency for Drugs and Technologies in Health (CADTH)

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2021